Observational studyInternational journal of oncology2021

Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.